ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 386

Rheumatoid Arthritis Is Associated With Systemic Inflammation In Coronary Vessels

Inge A.M. van den Oever1, Alper M. van Sijl1, Umit Baylan2, Michael. T. Nurmohamed1, Alexandre E. Voskuyl1, Hans W. Niessen2 and Suat Simsek3, 1Rheumatology, VU University Medical Center, Amsterdam, Netherlands, 2Pathology, VU University Medical Center, Amsterdam, Netherlands, 3Internal Medicine, Medical Center Alkmaar (MCA), Alkmaar, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis, coronary artery disease, inflammation and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects I: Comorbidities in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Patients with a chronic inflammatory disease (CID), particularly rheumatoid arthritis (RA), have an increased risk of fatal myocardial infarction (MI), as compared to the general population. This risk might be explained, in part, by an increased systemic inflammatory burden in CID causing coronary plaque instability. With tissue specimens of epicardial coronary arteries, we studied whether individuals with CID who died of a fatal MI have an increased influx of inflammatory cells, as compared to individuals without CID but with fatal MI.

 

Methods: All epicardial coronary artery tissue was collected from 11 individuals with CID (including RA) who had a fatal MI and controls without CID who also had a fatal MI. Controls were matched for age, gender and maximum stenosis of coronaries. Coronary arteries were immunohistochemically stained with specific antibodies against myeloperoxidase (neutrophilic granulocytes), CD45 (lymphocytes), CD68 (macrophages) and tryptase (mast-cells). Intramyocardial coronaries were stained with N-epsilon-(Carboxymethyl)lysine (CML), an advanced glycation end product, visualizing a pro-inflammatory status. Inflammatory cell density (cells/mm2) was calculated for each section of the coronary artery (intima, media and adventitia) for each stain. Subsequently, grade of coronary stenosis (0-100%) was measured. Correlations of grade of coronary stenosis and inflammatory cell density within each of these groups was calculated using the non-parametric Spearman’s Rank correlation.

 

Results: In RA patients, there was a significant correlation between grade of stenosis and inflammatory cell density of macrophages and lymphocytes in the intima of coronaries , with correlation coefficients of 0.313 (p < 0.05) and 0.205 (p < 0.05), respectively. This was also noted in granulocyte and mast-cell staining, but less strongly. These correlations were not observed in the control group and were also not observed in the media or adventitia of coronaries. Also, in patients with RA, a pro-inflammatory status of intramyocardial coronaries was shown, not only around the infarcted areas, but also in areas of the myocardium distant from MI.

 

Conclusion: Patients with RA who developed a fatal MI had a significant association between increasing grade of coronary stenosis and influx of inflammatory cells into the intima of all coronary arteries, irrespective of their relationship with the coronary implicated in MI. In particular, an increased influx of macrophages and lymphocytes was noted in the intima of all epicardial coronaries, as well as an increased endothelial activation of intramyocardial coronary vessels. The underlying inflammatory process in RA might drive a more inflammatory form of atherosclerosis, resulting in plaque vulnerability.

 

 

Figure 1. Scatter-plot depicting the correlation between inflammatory cell density of the intima and grade of stenosis of the epicardial coronary

 



Disclosure:

I. A. M. van den Oever,
None;

A. M. van Sijl,
None;

U. Baylan,
None;

M. T. Nurmohamed,
None;

A. E. Voskuyl,

Actelion Pharmaceuticals,

5;

H. W. Niessen,
None;

S. Simsek,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-is-associated-with-systemic-inflammation-in-coronary-vessels/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology